This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pujadas, R
Right arrow Articles by Mirelis, B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pujadas, R
Right arrow Articles by Mirelis, B

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1987 October; 31(10): 1474-1477

Efficacy of orally administered penicillin V for prophylaxis of experimentally induced streptococcal endocarditis.

R Pujadas, E Escriva, J Jane, M C Galera, P Fava, J Garau and B Mirelis

Department of Medicine, Hospital Central Q.S. La Alianza, Terrassa, Spain.

ABSTRACT

Four oral penicillin V regimens were compared for the ability to prevent Streptococcus sanguis infection of experimentally induced valvular heart lesions in rabbits. Challenge doses of 10(4), 10(6), and 10(8) CFU of a penicillin-susceptible strain of S. sanguis were used in this study. Measured by recovery of test organisms from endocardial lesions, the lowest-concentration inoculum was infective for 53% of the recipients; the higher-concentration inocula were infective for all recipients. A single-oral-dose penicillin V regimen (36 mg/kg of body weight) prevented endocarditis when rabbits were challenged with 10(4) CFU, but protection diminished with increasing inoculum concentrations. In contrast, addition of a second penicillin V dose (18 mg/kg of body weight) administered with a 7-h interval between doses achieved fully effective prophylaxis against even the highest inoculum tested (10(8) CFU). A repeated set of experiments in which half the dose of penicillin V was administered showed significantly reduced protection against S. sanguis endocarditis.


Antimicrob Agents Chemother. 1987 October; 31(10): 1474-1477